University of California, San Francisco
Otolaryngology residency · San Francisco, CA · Program website
- 2
- Faculty
- 25
- Trainees
- 335
- Papers
- 64%
- Trainees published
- 37%
- First author
2 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 335 in all. Updated 2026-11-07.
- Obesity and Pathologic Response to Neoadjuvant Immunotherapy in Head and Neck Cancer: Preliminary Results From a Pilot StudyAngeline Truong et al. · Head & Neck · 2026 · PubMed
- Wildfire Air Pollution Exposure and Head and Neck Cancer IncidenceYoun Soo Jung et al. · The Laryngoscope · 2026 · PubMed
- Surgical salvage improves survival for recurrent oral cavity and oropharyngeal squamous cell carcinoma in the era of immunotherapyIsaac H. Solomon et al. · Oral Oncology · 2026 · PubMed
- Outcomes of Osseous Microvascular Midface Reconstruction: Does Union Matter?Edgar Ochoa et al. · The Laryngoscope · 2026 · PubMed
- An rRNA hybridization-based approach for rapid and accurate identification of diverse fungal pathogensElizabeth A. Yee et al. · Microbiology Spectrum · 2026 · PubMed
- How Should Non‐Technical Skills Be Remediated in Surgical Specialties?Sophie E. Yu et al. · The Laryngoscope · 2026 · PubMed
- Behind the Podium: Surgical Residents’ Emotional Experiences at Morbidity and Mortality ConferencesKi Dong Kim et al. · Journal of surgical education · 2026 · PubMed
- Preoperative air-bone gap predicts thick stapes footplate requiring microdrill fenestration in otosclerosisVanessa J Zhang et al. · American Journal of Otolaryngology · 2026 · PubMed
- A timeline of recovery for post-COVID-19 olfactory dysfunction based on psychophysical performance: a scoping review and meta-analysisJeremy P. Tervo et al. · Scientific Reports · 2026
- Hearing Loss Is Associated With Regional Brain Amyloid in a Late Middle‐Aged CohortS. Dillon Powell et al. · The Laryngoscope · 2026 · PubMed
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 17 of 25 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Steven Pletcher, MD | Medical Education and Admissions; Sinusitis and nasal conditions | 29 | 22 | 1 | 7 | 5.49 |
| VyVy Young, MD | Voice and Speech Disorders; Dysphagia Assessment and Management | 19 | 50 | 4 | 8 | 1 |
25 trainees are counted above but never listed by name.
About University of California, San Franciscoinstitution-wide otolaryngology research
Otolaryngology publications from University of California, San Francisco and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
Works per year · * 2026 so far
Otolaryngology research topics at University of California, San Francisco
Papers in the window; each links to the list on OpenAlex.
Most cited at University of California, San Francisco since 2024
All otolaryngology papers there on OpenAlex
- NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025Alexander Dimitrios Colevas et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 228
- Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer PatientsSue Sun Yom et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · cited 80
- Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendationsChristina E. Henson et al. · The Lancet Oncology · 2024 · PubMed · cited 80
- Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K. Mell et al. · The Lancet Oncology · 2024 · PubMed · cited 70
- Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO GuidelineF. Christopher Holsinger et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 68
- International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)Shaojun Lin et al. · International Journal of Radiation Oncology*Biology*Physics · 2025 · PubMed · cited 30
- Post-operative radiotherapy for oral cavity squamous cell carcinoma: Review of the data guiding the selection and the delineation of post-operative target volumesMererid Evans et al. · Radiotherapy and Oncology · 2025 · PubMed · cited 27
- Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendationsAhmad Kamal Abou-Foul et al. · The Lancet Oncology · 2024 · PubMed · cited 26
- Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysisAllen S. Ho et al. · The Lancet Oncology · 2025 · PubMed · cited 24
- Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialHan Chong Toh et al. · Annals of Oncology · 2024 · PubMed · cited 24